CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-01 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −1,550 | 0 | ||
| 2023-09-01 | Mokari Atabak Chief Financial Officer | Grant or award | +398 | $33.10 | $13K | 7,806 |
| 2023-09-01 | Mokari Atabak Chief Financial Officer | Grant or award | +398 | 8,204 | ||
| 2023-09-01 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $11.35 | $57K | 10,132 |
| 2023-09-01 | Lyon Joseph Douglas Chief Accounting Officer | Sale 10b5-1 | −5,000 | $32.73 | $164K | 5,132 |
| 2023-09-01 | Lyon Joseph Douglas Chief Accounting Officer | Grant or award 10b5-1 | +361 | $33.10 | $12K | 5,493 |
| 2023-09-01 | Lyon Joseph Douglas Chief Accounting Officer | Grant or award 10b5-1 | +361 | 5,854 | ||
| 2023-09-01 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 59,167 | ||
| 2023-09-01 | Robb Gary Charles Chief Business Officer | Grant or award | +500 | $33.10 | $17K | 20,529 |
| 2023-09-01 | Robb Gary Charles Chief Business Officer | Grant or award | +500 | 21,029 | ||
| 2023-09-01 | Maduck Sean See Remarks | Grant or award | +456 | $33.10 | $15K | 73,154 |
| 2023-09-01 | Maduck Sean See Remarks | Grant or award | +456 | 73,610 | ||
| 2023-09-01 | Guyer William Chief Development Officer | Grant or award | +478 | $33.10 | $16K | 5,266 |
| 2023-09-01 | Guyer William Chief Development Officer | Grant or award | +478 | 5,744 | ||
| 2023-08-29 | MAHONEY DAVID L Director | Gift | −17,420 | 1,204,658 | ||
| 2023-08-29 | MAHONEY DAVID L Director | Gift | −34,850 | 1,169,808 | ||
| 2023-08-29 | MAHONEY DAVID L Director | Gift | +34,850 | 46,147 | ||
| 2023-08-21 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise 10b5-1 | +3,755 | $8.27 | $31K | 8,887 |
| 2023-08-21 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise 10b5-1 | +833 | $11.35 | $9K | 9,720 |
| 2023-08-21 | Lyon Joseph Douglas Chief Accounting Officer | Sale 10b5-1 | −4,588 | $31.19 | $143K | 5,132 |
Page 48 of 61 · 1,220 trades